VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 300 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2017. The put-call ratio across all filers is 2.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $337,000 | -22.7% | 14,500 | -47.1% | 0.12% | -27.0% |
| Q1 2018 | $436,000 | -26.0% | 27,400 | -3.4% | 0.16% | -25.4% |
| Q4 2017 | $589,000 | +56.2% | 28,350 | +7.8% | 0.21% | +47.9% |
| Q3 2017 | $377,000 | -16.8% | 26,300 | +0.4% | 0.14% | -20.4% |
| Q2 2017 | $453,000 | +141.0% | 26,200 | +54.1% | 0.18% | +135.1% |
| Q1 2017 | $188,000 | +8.0% | 17,000 | +41.7% | 0.08% | +5.5% |
| Q4 2016 | $174,000 | – | 12,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |